Geisinger Chair of Pediatrics: Rising Theat of Marijuana Edibles Between legalization in many surrounding states and the increased amount of people with medical use cards, the use of tetrahyocannabinol or THC, has increased dramatically in the past decade. The surge in popularity of edible cannabis products has allowed users to be discreet, while eliminating odor and potential harm to the lungs. However, the packaging of these products is appealing to children. Most people don’t know, that THC, the principal psychoactive compound found in cannabis, can be extremely toxic to children. In our communities and at our children’s hospital, there has been an alarming rise of accidental poisonings of children due to synthetic marijuana. It is a growing threat that demands our attention and immediate action. In 2024, we had more than a dozen children brought to our hospital for THC poisoning. We recently admitted two young children to our pediatric intensive care unit (PICU) on the same day with life threatening consequences from cannabis exposure. Young children who unknowingly ingest THC-laced products often present with significant medical emergencies, including profound lethargy, respiratory depression, seizures, and, in severe cases, coma or even near-cardiac arrest. Nearly 10 percent of children suffering from these ingestions require support in a PICU. Recent data from the Centers for Disease Control and Prevention (CDC) reveals a dramatic increase in the rate of overdoses. In 2017, there were 207 reported cases of accidental edible cannabis exposure for kids under the age of 6. By 2021, the number skyrocketed to 3,054, and these numbers continue to increase. Toddlers are disproportionately affected due to their small size and developing metabolism, making even small quantities extremely toxic. In June 2022, the Food and Drug Administration released a consumer alert warning that THC-containing edibles are easily mistaken for products that might appeal to children. By Frank Maffei, Geisinger chair of pediatrics
Geisinger to Host Education Event: Medical Marijuana in PA As part of its ongoing series of community health education programs, Geisinger Commonwealth School of Medicine will host “Medical Marijuana in Pennsylvania” on Thursday, July 27 at 5:30 p.m. at the school’s Medical Sciences Building at 525 Pine Street. This session will inform the public on: Identify evidence for benefits of medical marijuana useThe risks of medical marijuana useHow physicians certify patients for medical marijuana use Victor O. Kolade, MD, MS, clinical professor of medicine, will discuss the latest research on medical marijuana and explore data regarding its efficacy for certain health conditions. There will also be time for questions. Board certified in internal medicine, Dr. Kolade is an internist at Guthrie Robert Packer Hospital in Sayre. See for details: To register visit go.geisinger.edu/communityedseries.